[Aprepitant and pruritus--comment].
Oddeleni radioterapie a onkologie, Nemocnice Novy Jicin. viktor.manasek@onkologickecentrum.cz
V
V
Manasek
D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000077608:Aprepitant; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents; D009025:Morpholines; D000077608:Aprepitant